13 January 2022

A team from the Essex Innovation Centre, a strategic partnership between the University of Essex and TWI, is currently working with fellow consortium members Generic Robotics Limited and Castalia Innovation Limited on the NeuRestore project which seeks to aid patients that have suffered a stroke, or other ailments that resulted in the loss of mobility, by improving their hand and arm movement recovery without the constant need for specialist physiotherapists.

According to SAFE, the Stroke Alliance for Europe, over 13.7 million new strokes happen each year, and statistics have also shown that up to 80% of stroke survivors face upper limb impairment. However, a number of patients can overcome this condition around six months after the incident, even achieving full motor recovery, through neuro-rehabilitation and the brain’s ability to adapt to new incoming information and undertake a form of self-healing called neuroplasticity.

Yet, existing advanced neuro-rehabilitation techniques are faced with a variety of limitations. To address this and further support the chances of patient recovery, NeuRestore aims to become a cost-effective (£98,000 licensed unit/year) and non-invasive brain-computer interface (BCI), specifically tailored for motor rehabilitation of upper limb weakness in stroke survivors without the continuous intervention of specialist physiotherapists.

The NeuRestore consortium was able to commence the project because of winning Innovate UK funding in 2019. Each partner is responsible for delivering different parts of the BCI with Generic Robots focussing on constructing a robotic exoskeleton that covers the whole hand and arm, Castalia Innovation developing the virtual reality (VR) component of the project, and the Essex Innovation Centre working on the algorithmic model and the integration with the robotic exoskeleton.

NeuRestore uses relatively inexpensive EEG (electroencephalogram) devices to monitor and record the brain's electrical patterns while simultaneously receiving trigger feedback or an action output. To achieve a comprehensive picture of cerebral activity, motor imagery (imagining a movement) is employed. With the repetition of mental images of movements, an algorithmic model is calibrated to identify and classify when the patient shows the true intention of movement. The trained model is then paired with a robotic hand exoskeleton so that action outputs are generated from classifying the brain signals, and the movement of the robotic fingers is synchronized with them. The whole process becomes even more immersive when the patient enters a virtual 3D environment where they can see their hand move, providing a more realistic visual output of their imagined movement. This VR dimension can greatly help with building a stronger link between brain signals and subsequent real-life physical movements.

In September 2021, NeuRestore was demonstrated at the University of Essex’s Knowledge Transfer Partnership Awards event, giving an insight into progress so far and the further development planned. The demo session utilized a simple EEG ‘Muse Brain-Sensing Headband’ and a pair of exoskeletons, with the user wearing the first exoskeleton one and the second being positioned at a distance. This setup showed that the exoskeleton motions were exclusively triggered by the algorithmic model being able to classify the EEG signals and were not the output of the healthy user’s movements.

Panos Chatzakos, director of the Essex Innovation Centre, said: “This project is enabled by the complementary expertise and experience of the consortium partners who, together, are combining their knowledge of advanced medical technologies development and application to deliver a brand new support system for stroke patients, that is both affordable and proven effective at making a real difference to people’s recovery.”

This article was originally posted by: MED-TECH INNOVATION


Sign Up

Cookie Policy

We use cookies to personalise content and ads, to provide social media features and to analiyse our trafic.We may also share information about your use of our site with our social media, advertising and analytics partners. Learn more

I understand